Skip to main content

Record high numbers of presenting companies at major Scandinavian investor meeting arranged by SwedenBIO

Press release   •   Mar 16, 2012 15:00 EDT

Life Science Investment Day Scandinavia is one of the biggest investment events in life science. This year, over 45 presenting companies will be seeking contacts for sales, in-and out-licensing and partnerships with investors from Europe, the US, China and Japan. Between 300 and 400 people are expected to visit the event, organized by industry association SwedenBIO in affiliation with partners such as Gold Partner Bird & Bird.

“I was pleasantly surprised to see quite few new companies (does not happen all the time at conferences these days) so definitely worth the trip for me. Also just wanted to compliment you on a very professional organization,” says Roel Bulthuis, Head of Merck Serono Ventures.

“Life Science Investment Day Scandinavia is the most important recurring business-oriented life science meeting in Sweden, “says Kancera CEO Thomas Olin, who will present the company's strategy and cancer drug discovery projects at the event. “Having an international meeting on our own territory is extremely important to visualize the quality and breadth of Scandinavian research and development. It is one of the few meetings in Scandinavia where we can attract a critical mass of investors and corporations.”

Sweden – despite its size – is one of the world’s most innovative countries. A number of Swedish biotech companies are now looking to commercialize their projects, to take the next step towards growth and profitability. Meanwhile, larger companies, while cutting back on internal research, are increasingly dependent on external innovation and collaboration. Globally, the business climate within the industry is undergoing a shift, opening the door to new business models in which companies deliver prototypes or ready-to-market drugs, in line with each company's own direction and ability to find funding.

“We know that meetings such as Life Science Investment Day Scandinavia enable the very survival of several companies,” says SwedenBIO’s head of business development and finance Jonas Ekstrand, who organizes the event. “Our aim is to have a new Pharmacia and Astra, so points of contact such as this event are one of many ways for us to help.”

In addition to the companies presenting, the event program features international speakers such as Grace Chen from Bird & Bird, who will speak about the Chinese market, Nigel Whittle from UK Trade & Investment on the UK's life sciences strategy, and Piyush Unalkat from the European Investment Fund, who will discuss venture capital for entrepreneurs and innovators.

“Sweden is a prestigious country in life science,” says SwedenBIO CEO Johan Järte, “and we envisage significant interest in us from global companies. For our members to have the best environment to develop and remain in Sweden requires cooperation on all fronts: regionally and internationally, between different professional categories and cross-industry alliances.”

Now in its seventh year, this is the first time Life Science Investment Day Scandinavia is being held outside Stockholm, hosted by the city of Malmö. The presenting companies come from Sweden, Denmark, Norway and Finland.

Life Science Investment Day Scandinavia will take place at the Hilton Malmo City, on 27 March 8.00 am - 5.15 pm.

Read more at Read the program here, the full conference program with company presentations here and about presenting companies here.

Join us on Twitter with #LSID2012

In collaboration with Life Science Investment Day Scandinavia, Nordic Journal of Chemistry & Biotechnology is organizing a sister event the following day in Lund: “The Future of Swedish and Danish Life Science."




Karina Eskilsson, Communications & PR Manager, SwedenBIO +46 70 420 33 74,

SwedenBIO helps innovative companies succeed! SwedenBIO is the national organization working for the benefit of the entire life science sector in Sweden - a member driven, private non-profit organization. The main objective is to improve and maintain industry conditions which will support prosperous growth and business development among our, today, close to 200 member companies. Our members are active in the fields of pharmaceutical, biotech, medtech and diagnostics. Our mission is to create visibility and interest for the Swedish life science and thereby support a successful life science industry. A successful industry can heal and help those patients still suffering from unmet medical needs. A successful industry creates jobs and welfare and creates opportunities for a healthier and brighter future. We’ve been successfully doing this for 10 years.

Attached Files

PDF document

Comments (0)

Add comment


By submitting the comment you agree that your personal data will be processed according to Mynewsdesk's Privacy Policy.